countervova.blogg.se - Bardy diagnostics press release

BARDY DIAGNOSTICS PRESS RELEASE PATCH

Brit Baird – Baird has been promoted from Sr.

Prior to BardyDx, she served in the Cardiac Rhythm Management division at Medtronic and Biotronik. With over 17 years of experience in cardiology and electrophysiology, Mynhier has managed and grown BardyDx’s ECG monitoring center located in Houston, Texas. Director to VP of Clinical Services & Customer Experience.

Liz Mynhier – Mynhier has been promoted from Sr.

Gutierrez possesses over 19 years of experience and has held senior marketing and sales positions at MedBridge, Athios Health, Velano Vascular, FoxHollow Technologies (acquired by ev3 and Covidien), and Cordis. She brings cardiac monitoring experience having formerly served as Director of Marketing at iRhythm Technologies. Cristina Gutierrez – Gutierrez has been appointed VP of Market Development & Training.Bardy and the innovative team at BardyDx, and I am excited and eager to help further the company’s success.”īardyDx also announced today the following additions to its Leadership Team:

BARDY DIAGNOSTICS PRESS RELEASE PATCH

“BardyDx is experiencing accelerating growth with the success of the CAM patch and the development of novel ECG analysis technologies,” said Vertatschitsch. Vertatschitsch possesses strong cross-industry development experience, including leadership roles at Palm and Boeing. Previously, he also served as EVP Operations and R&D and VP of Engineering at Calypso Medical. Vertatschitsch joined Varian Medial Systems following the acquisition of Calypso Medical, where he was President and CEO. Prior to joining BardyDx, Vertatschitsch served as VP of Global Portfolio Solutions, VP of Treatment and Imaging Solutions – Delivery Systems, and General Manager at Varian Medical Systems. We are thrilled to have him join our team as we continue to expand our product line and rapidly broaden our customer base.” “Vertatschitsch brings a wealth of operational and development experience across the spectrum from early-stage to large-sized companies. “We are pleased to have Ed Vertatschitsch join BardyDx’s executive team,” said Gust Bardy, MD, Bardy Diagnostics’ Founder and Chief Executive Officer. With over 17 years in the medical device industry, Vertatschitsch will be responsible for leading all operations, research & development, and regulatory and quality affairs functions. 13, 2020 /PRNewswire/ - Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, including the Carnation Ambulatory Monitor (“CAM™"), the only P-wave centric™ ambulatory cardiac patch monitor and arrhythmia detection device, announced today the appointment of Ed Vertatschitsch as Chief Operating Officer effective January 2, 2020.